ISPC stock news · iSpecimen Inc.
Get alerts for ISPC
Follow iSpecimen Inc. (ISPC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ISPCiSpecimen Inc. shareholders agreed to a reverse stock split, which will be set between 1-for-10 and 1-for-100.
NeutraliSpecimen stockholders approved permission for a reverse stock split, but the board has not set the ratio. This vote alone does not change the company’s outlook.
12 health care stocks are changing in price before the market opens, with NRX Pharmaceuticals going up and Acumen Pharmaceuticals dropping.
NeutraliSpecimen shares rose about 9% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.
12 health care stocks are changing a lot before the market opens on Thursday.
NeutraliSpecimen shares fell about 10%, but the article gives no company news explaining the move. It does not change the company's outlook.
12 health care stocks changed a lot in prices during Thursday's after-hours trading.
NeutraliSpecimen shares fell 6.79% after hours. The article gives no company update or reason, so this move alone does not change its business outlook.
iSpecimen Inc. announces the establishment of a significant definitive agreement (ISPC).
NeutraliSpecimen Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is likely to have a positive impact on its business strategy and investor sentiment.
iSpecimen Inc. announces the establishment of a significant definitive agreement (ISPC).
NeutraliSpecimen Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is a significant development that could enhance its operational capabilities and market position. This news is likely to be viewed positively by investors as it suggests potential growth opportunities.
iSpecimen Inc. announces the establishment of a significant definitive agreement (ISPC).
Good for ISPCiSpecimen Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is a significant development that could enhance its business prospects and investor confidence. This news is likely to attract attention from investors looking for growth opportunities in the healthcare sector.